文献速递生殖医学

多囊卵巢综合征患者生育治疗提供的种族和社会经济差异

Racial and socioeconomic disparities in fertility treatment provision for patients with polycystic ovary syndrome.
PubMed 文献 · Fertil Steril · 2024-06-22

本研究为回顾性队列研究,纳入2007-2021年大学健康系统中因多囊卵巢综合征(PCOS)和不孕就诊的3,435例患者,分析生育治疗处方与患者及医生人口学特征的关联。结果显示黑人患者、收入低于联邦贫困线者及公共保险者接受处方的 odds 较低,且黑人患者从初诊到获得处方平均等待时间比白人患者长153.3天。

要点

  • 黑人患者接受生育治疗处方的 odds 低于白人患者(aOR 0.75,95%CI 0.61-0.93)。
  • 估计家庭收入低于联邦贫困线者相比高于全国中位数者处方 odds 更低(aOR 0.71,95%CI 0.46-0.97)。
  • 公共保险者相比商业保险者处方 odds 更低(aOR 0.53,95%CI 0.40-0.71)。

核心结论

  • PCOS患者生育治疗提供中存在种族和社会经济差异。
  • 参与一线生育治疗的全科医生较少,提示可通过医生教育改善生育照护可及性。

研究设计与样本

  • 回顾性队列研究,设置于大学健康系统。
  • 纳入2007-2021年因PCOS和不孕就诊的患者,共3,435例,平均年龄31.1±5.7岁。

主要发现

  • 68.8%的患者接受了处方,其中47.8%为枸橼酸氯米芬(CC),38.6%为来曲唑,13.7%为注射用促性腺激素。
  • 黑人患者相比白人患者处方 odds 更低(aOR 0.75,95%CI 0.61-0.93)。
  • 估计家庭收入低于联邦贫困线者相比高于全国中位数者处方 odds 更低(aOR 0.71,95%CI 0.46-0.97)。
  • 公共保险者相比商业保险者处方 odds 更低(aOR 0.53,95%CI 0.40-0.71)。
  • 黑人患者从初诊到获得处方平均比白人患者多等待153.3天。

关键数值与推荐

  • 仅在口服药物处方亚组分析中,黑人相比白人处方 odds 更低(aOR 0.74,95%CI 0.57-0.95)。
  • 仅在口服药物处方亚组分析中,估计家庭收入低于联邦贫困线者相比高于全国中位数者处方 odds 更低(aOR 0.93,95%CI 0.87-0.98)。
  • 仅在口服药物处方亚组分析中,公共保险者相比商业保险者处方 odds 更低(aOR 0.57,95%CI 0.42-0.76)。
  • 家庭医学医生相比生殖内分泌医生,患者接受任何处方的 odds 更低(aOR 0.36,95%CI 0.24-0.52)。
  • 普通内科医生相比生殖内分泌医生,患者接受任何处方的 odds 更低(aOR 0.55,95%CI 0.42-0.73)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess whether the provision of fertility treatment for patients with polycystic ovary syndrome (PCOS) varies by patient and physician-level demographic characteristics. DESIGN: Retrospective cohort study. SETTING: University health system. PATIENT(S): Patients seeking care for PCOS and infertility from 2007-2021. INTERVENTION(S): Patient age, body mass index, race, ethnicity, estimated household income, primary insurance payor, provider sex, and provider medical specialty. MAIN OUTCOME MEASURE(S): Prescriptions for fertility treatment, including clomiphene citrate (CC), letrozole, and injectable gonadotropins. Differences in patient and physician demographics between patients who did as well as did not receive a prescription were identified with univariable analysis. Multilevel mixed-effects logistic regression was performed to determine associations between patient and physician demographics and prescription receipt. RESULT(S): A total of 3,435 patients with PCOS and infertility were identified, with a mean age of 31.1 ± 5.7 years. Of the 68.8% of patients who received a prescription, 47.8% of prescriptions were CC, 38.6% were letrozole, and 13.7% were injectable gonadotropins. There were lower odds of prescription receipt for Black patients compared with White patients (adjusted odds ratio [aOR], 0.75; 95% confidence interval [CI], 0.61-0.93), those with estimated household income below the federal poverty level compared with those above the national median (aOR, 0.71; 95% CI, 0.46-0.97), and those with public compared with commercial insurance (aOR, 0.53; 95% CI, 0.40-0.71). These disparities persisted in a subanalysis of patients prescribed oral medications only with lower odds of prescription receipt for Black compared with White patients (aOR, 0.74; 95% CI, 0.57-0.95), those with estimated household income below the federal poverty level compared with above the national median (aOR, 0.93; 95% CI, 0.87-0.98), and those with public compared with commercial insurance (aOR, 0.57; 95% CI, 0.42-0.76). Black patients waited, on average, 153.3 days longer than White patients, from the initial visit to the prescription receipt. Patients had lower odds of receiving any prescription from family medicine physicians (aOR, 0.36; 95% CI, 0.24-0.52) and general internal medicine physicians (aOR, 0.55; 95% CI, 0.42-0.73) compared with reproductive endocrinologists. CONCLUSION(S): Racial and socioeconomic disparities exist in the provision of infertility treatments for patients with PCOS. Fewer primary care physicians engaged in first-line fertility treatment, indicating an opportunity for physician education to improve access to fertility care.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Applebaum J, Kim EK, Sharp M, et al. Racial and socioeconomic disparities in fertility treatment provision for patients with polycystic ovary syndrome. Fertil Steril. 2024. PMID: 38909670. doi:10.1016/j.fertnstert.2024.06.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。